Performance and Safety of Joline® Kyphoplasty Single Balloon Catheter Allevo vs. Quattroplasty Double-Balloon Catheter Stop'n GO With BonOs® Inject Bone Cement
Sponsored by University Hospital Tuebingen
About this trial
Last updated 5 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 4 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- patients aged ≥18 years
- 1-3 painful VCF(s), of which at least 1 meets the following criteria:
- Investigator estimates that target VB(s) is/ are suitable for Quattroplasty double balloon catheter or Kyphoplasty single balloon catheter (e.g. appropriate pedicle diameter, no cortical bone protruding into the spinal canal).
- Patient has an ODI score of 30% or more.
- Patient is willing and able to comply with study requirements.
- Patient signs informed consent form.
- Women who are post-menopausal, surgically sterile or on contraceptives and agree to remain on contraceptives for the duration of their study participation and agree not to become pregnant during the study.
Exclusion Criteria
- Segmental kyphosis of target VB of >30°
- Pre-existing or clinically unstable neurologic deficit
- Any physical exam evidence of myelopathy or radiculopathy
- Not able to walk without assistance prior to fractures
- Any radiographic evidence of pedicle fracture or interspinous-process widening
- Spondylolisthesis >grade 1 at target VB(s)
- History of spine surgery, including prior vertebral augmentation, during the last year
- Any underlying systemic bone disease other than osteoporosis (e.g. osteomalacia, osteogenesis imperfect, etc.)
- Irreversible coagulopathy and/or taking peri-operatively warfarin (Coumadin) or other anticoagulant
- Pregnancy and nursing
- Pain due to any other condition that requires daily narcotic medication
- Disabling back pain due to causes other than acute fracture
- History of intolerance, or allergic reaction to titanium or acrylic compounds
- Active systemic or local infection at baseline
- Severe cardiopulmonary disease (e.g. stage IV heart failure, severe chronic obstructive pulmonary disease)
- Any other medical illness or condition that, in the investigator's opinion, is likely to impair long-term follow-up (e.g. cancer) or greatly increase the risk of surgery
- Any evidence of substance abuse
- The patient is on long-term steroid therapy (steroid dose 30 mg/day for >3 months)
- The patient is known to be involved in medical litigation including Workmen's compensation.
- Patient with contraindication for MRI including but not limited to patients with contraindications for general anesthesia (surgeon expertise)
- Patient who is contraindicated for the use of PMMA cement
- Patients who belong to a vulnerable population or that are not able to sign the informed consent form.
- Patients where the VCF was treated in combination with fusion.
- Patients with any contraindication according to the IFU